Ventripoint and First Light Health Launch AI Cardiac Imaging Network for Remote Indigenous Communities

VentriPoint Diagnostics ( (TSE:VPT) ) has issued an announcement.

Ventripoint Diagnostics has partnered with Indigenous-owned First Light Health to deploy its AI-assisted VMS+ cardiac imaging system in a hub-and-spoke network serving Indigenous and remote communities across British Columbia and other Canadian regions. The model allows local providers to perform echocardiograms on-site and send enhanced scans to urban hubs for specialist interpretation, reducing travel, wait times, and costs for populations with disproportionately high cardiovascular risk.

By leveraging MRI-level accuracy at a fraction of the cost and time, the collaboration aims to close critical gaps in cardiac diagnostics and align advanced technology with culturally safe, trauma-informed care models. Ventripoint is positioning this initiative as a scalable template for equitable heart care, with plans to expand the network nationally and into international markets where its VMS+ system is already approved, potentially strengthening its market presence in underserved healthcare segments.

The most recent analyst rating on (TSE:VPT) stock is a Hold with a C$0.12 price target. To see the full list of analyst forecasts on VentriPoint Diagnostics stock, see the TSE:VPT Stock Forecast page.

Spark’s Take on VPT Stock

According to Spark, TipRanks’ AI Analyst, VPT is a Neutral.

The score is held back primarily by weak financial fundamentals (ongoing losses, cash burn, and negative equity). Technicals are moderately constructive with improving momentum, and corporate updates are directionally positive, but valuation support is limited due to negative earnings and no dividend indicated.

To see Spark’s full report on VPT stock, click here.

More about VentriPoint Diagnostics

Ventripoint Diagnostics Ltd. is a Toronto-based medical technology company specializing in artificial intelligence for echocardiography, with a flagship VMS+ system that converts standard 2D ultrasound scans into MRI-accurate 3D cardiac measurements. Approved for use in the U.S., Canada, and Europe and compatible with ultrasound systems from any vendor, the platform targets accessible, cost-effective, gold-standard cardiac imaging for clinicians and patients worldwide.

Average Trading Volume: 115,414

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$20.64M

For detailed information about VPT stock, go to TipRanks’ Stock Analysis page.